Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
NCT01323478
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Vortioxetine (Lu AA21004)
Sponsor
H. Lundbeck A/S